Alan Shaw

President, CEO and Co-Founder, Calysta

PhD in Chemistry, University of Durham. Formerly: in various scientific, business development and sales and marketing posts in the chemicals industry; Managing Director and Member of the Board, Chirotech Technology (fine chemicals division of ChiroScience Group); Chief Operating Officer, Archimica Fine Chemicals (fine chemicals division of BTP); until 2001, Head, New Business Development and Managing Director, Lancaster Synthesis Group, Clariant Life Science Molecules (Clariant's Life Science and Electronics division); also, Member, Clariant Life Science Molecules Executive Management Team. Since September 2001, Maxygen.

About Us



Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum